Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002663128 | SCV002979347 | uncertain significance | Cranioectodermal dysplasia 1 | 2022-08-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with IFT122-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant is present in population databases (rs372561450, gnomAD 0.007%). This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 1220 of the IFT122 protein (p.Ser1220Thr). |
Fulgent Genetics, |
RCV002663128 | SCV005661433 | uncertain significance | Cranioectodermal dysplasia 1 | 2024-06-17 | criteria provided, single submitter | clinical testing |